These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34130280)

  • 21. Emerging Individualized Approaches in the Management of Acute Cardiorenal Syndrome With Renal Assist Devices.
    Martens P; Burkhoff D; Cowger JA; Jorde UP; Kapur NK; Tang WHW
    JACC Heart Fail; 2023 Oct; 11(10):1289-1303. PubMed ID: 37676211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of acute kidney injury in acute decompensated heart failure: identifying true cardiorenal syndrome and unveiling prognostic significance.
    Thanapongsatorn P; Tanomchartchai A; Assavahanrit J
    Kidney Res Clin Pract; 2024 Jul; 43(4):480-491. PubMed ID: 38934031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiorenal Syndrome.
    Ricci Z; Romagnoli S; Ronco C
    Crit Care Clin; 2021 Apr; 37(2):335-347. PubMed ID: 33752859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ultrafiltration versus intravenous furosemide for decompensated heart failure in cardiorenal syndrome: a systematic review with meta-analysis of randomized controlled trials.
    Chen HY; Chou KJ; Fang HC; Chen CL; Hsu CY; Huang WC; Huang CW; Huang CK; Lee PT
    Nephron; 2015; 129(3):189-96. PubMed ID: 25765606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.
    Atici A; Emet S; Cakmak R; Yuruyen G; Alibeyoglu A; Akarsu M; Arman Y; Kose M; Ozgun E; Ozcan M; Altun O; Onur I; Tukek T
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3534-3543. PubMed ID: 29917208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure.
    Patarroyo M; Wehbe E; Hanna M; Taylor DO; Starling RC; Demirjian S; Tang WH
    J Am Coll Cardiol; 2012 Nov; 60(19):1906-12. PubMed ID: 23062527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
    Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L
    Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of Cardiorenal Syndrome to Mitral and Tricuspid Regurgitation in Acute Decompensated Heart Failure.
    Seghatol FF; Martin KD; Haj-Asaad A; Xie M; Prabhu SD
    Am J Cardiol; 2022 Apr; 168():99-104. PubMed ID: 35045927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.
    Freda BJ; Slawsky M; Mallidi J; Braden GL
    Am J Kidney Dis; 2011 Dec; 58(6):1005-17. PubMed ID: 22014726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous Veno-Venous Hemofiltration Improves Survival of Patients With Congestive Heart Failure and Cardiorenal Syndrome Compared to Slow Continuous Ultrafiltration.
    Premuzic V; Basic-Jukic N; Jelakovic B; Kes P
    Ther Apher Dial; 2017 Jun; 21(3):279-286. PubMed ID: 28403554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.
    Ronco C; Cicoira M; McCullough PA
    J Am Coll Cardiol; 2012 Sep; 60(12):1031-42. PubMed ID: 22840531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey.
    Dos Reis D; Fraticelli L; Bassand A; Manzo-Silberman S; Peschanski N; Charpentier S; Elbaz M; Savary D; Bonnefoy-Cudraz E; Laribi S; Henry P; Guerraoui A; Tazarourte K; Chouihed T; El Khoury C
    BMJ Open; 2019 Jan; 9(1):e022776. PubMed ID: 30782685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Cardiorenal Syndrome in Heart Failure.
    Costanzo MR
    Heart Fail Clin; 2020 Jan; 16(1):81-97. PubMed ID: 31735318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute Kidney Injury, Type - 3 cardiorenal syndrome, Biomarkers, Renal Replacement Therapy].
    Di Lullo L; Bellasi A; Barbera V; Cozzolino M; Russo D; De Pascalis A; Santoboni F; Villani A; De Rosa S; Colafelice M; Russo L; Ronco C
    G Ital Nefrol; 2016; 33(3):. PubMed ID: 27374388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arteriovenous renal replacement therapy in end-stage left-sided heart failure patients has a detrimental effect on patients with impaired right ventricular function.
    Repasos E; Kaldara E; Pantsios C; Kapelios C; Nana E; Vernadakis S; Melexopoulou C; Malliaras K; Boletis J; Nanas JN
    Hellenic J Cardiol; 2017; 58(4):276-280. PubMed ID: 27890630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiorenal syndrome and the role of ultrafiltration in heart failure.
    Prosek J; Agarwal A; Parikh SV
    Curr Heart Fail Rep; 2013 Mar; 10(1):81-8. PubMed ID: 23354831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes prevalence and outcomes in hospitalized cardiorenal-syndrome patients with and without hyponatremia.
    Pliquett RU; Schlump K; Wienke A; Bartling B; Noutsias M; Tamm A; Girndt M
    BMC Nephrol; 2020 Sep; 21(1):393. PubMed ID: 32912147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cardiorenal Syndrome in Heart Failure.
    Costanzo MR
    Cardiol Clin; 2022 May; 40(2):219-235. PubMed ID: 35465896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Improvement effect of early goal-directed therapy on the prognosis in patients with septic shock].
    Li C; Yun D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Nov; 27(11):899-905. PubMed ID: 27132457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent renal replacement therapy for end stage drug refractory heart failure.
    Repasos E; Kaldara E; Ntalianis A; Pantsios C; Kapelios C; Nana E; Grapsa E; Malliaras K; Nanas JN
    Int J Cardiol; 2015 Mar; 183():24-6. PubMed ID: 25662049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.